In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Acrinol Drug Master File in Korea (Acrinol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Acrinol. The MFDS reviews the Acrinol KDMF as part of the drug registration process and uses the information provided in the Acrinol KDMF to evaluate the safety and efficacy of the drug.
After submitting a Acrinol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Acrinol API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Acrinol suppliers with KDMF on PharmaCompass.